The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 351:824-826 August 19, 2004 Number 8
NextNext

Circulating Tumor Cells in Metastatic Breast Cancer — Toward Individualized Treatment?
Stephan Braun, M.D., and Christian Marth, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Cristofanilli, M.
-PubMed Citation
When Steven Paget published his theory of "seed and soil" in 1889,1 the idea of hematogenous tumor-cell dissemination was born. More than a century later, with the use of molecular tools, new clinical findings have resulted in explanations of hither-to unexplainable phenomena, such as that donor-derived cancer in recipient organ allografts2 and viable single tumor cells in secondary organs were both the descendants of a known primary tumor3 and the potential precursors of subsequent metastasis.4 Now, as shown by Cristofanilli et al.5 in this issue of the Journal, a laboratory assay of circulating tumor cells enables us to predict a . . . [Full Text of this Article]


Source Information

From the Department of Gynecology and Obstetrics and the Breast Health Center, Innsbruck Medical University, Innsbruck, Austria.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.